速递｜AI科研独角兽Lila Sciences获2.35亿美元融资，估值12.3亿美元冲刺AI生成新药与材料

Core Insights - Lila Sciences, a biotechnology company, has raised $235 million at a valuation of approximately $1.23 billion, aiming to accelerate scientific discovery through AI tools [1][5]. Group 1: Company Overview - Lila exited stealth mode after completing a $200 million seed round in March and is developing AI systems trained on academic literature in materials science, chemistry, and life sciences [2]. - The company is establishing "AI science factories" where human researchers and software collaborate on automated research, with the goal of developing new materials for carbon capture and drug discovery [2][3]. Group 2: Competitive Advantage - Lila believes that building dedicated automated laboratories will create a competitive edge, having already discovered thousands of new proteins, nucleic acids, chemicals, and materials since its founding in 2023 [3]. - The company has not yet commercialized any products but has received interest from external companies for collaboration using its AI systems and laboratories [3]. Group 3: Investment and Growth Potential - The latest funding round was led by Braidwell and Collective Global, with participation from ARK Venture Fund and General Catalyst, highlighting Lila's ability to attract top AI and research talent [5]. - The potential for rapid development of materials, drugs, and patents is seen as highly attractive by investors [5][6].